Transitory FGF treatment results in the long-lasting suppression of the proliferative response to repeated FGF stimulation

Journal of Cellular Biochemistry

Volumn 115, Issue 5, 2014, Pages 874-888

  Poole, Ashleigh ^a   Knowland, Nicholas ^a   Cooper, Emily ^a   Cole, Rebecca ^a   Wang, Hongchuan ^a   Booth, Lucas ^a   Kacer, Doreen ^a   Tarantini, Francesca ^b   Friesel, Robert ^a   Prudovsky, Igor ^a  

^a Maine Medical Center Research Institute   (United States)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

CELL MEMORY; CELL MIGRATION; DNA SYNTHESIS; FGF; HDAC; NF B

Indexed keywords

CYCLIN A; CYCLIN D1; DNA; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIVISION; CELL PROLIFERATION; CELL STIMULATION; CELL STRUCTURE; DNA REPLICATION; DNA SYNTHESIS; ENZYME PHOSPHORYLATION; FIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

CELL " MEMORY"; CELL MIGRATION; DNA SYNTHESIS; FGF; HDAC; NFΚB;

ANIMALS; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN D1; DNA REPLICATION; FIBROBLAST GROWTH FACTORS; G1 PHASE; HISTONE DEACETYLASES; MAP KINASE SIGNALING SYSTEM; MICE; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 84895536884     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24731     Document Type: Article

References (30)

1. Andreeva V, Prudovsky I, Maciag T,. 2004. Stimulation of quiescent cells by individual polypeptide growth factors is limited to one cell cycle. Euro J Cell Biol 83: 327-335.
2. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M,. 2008. Growth factors and cytokines in wound healing. Wound Repair Regen 16: 585-601.
3. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, et al. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363-9367.
4. Ford-Perriss M, Abud H, Murphy M,. 2001. Fibroblast growth factors in the developing central nervous system. Clin Exp Pharmacol Physiol 28: 493-503.
5. Forough R, Engleka K, Thompson JA, Jackson A, Imamura T, Maciag T,. 1991. Differential expression in Escherichia coli of the alpha and beta forms of heparin-binding acidic fibroblast growth factor-1: Potential role of RNA secondary structure. Biochim Biophys Acta 1090: 293-298.
6. Friesel R, Maciag T,. 1988. Internalization and degradation of heparin binding growth factor-I by endothelial cells. Biochem Biophys Res Commun 151: 957-964.
7. Friesel R, Maciag T,. 1999. Fibroblast growth factor prototype release and fibroblast growth factor receptor signaling. Thromb Haemost 82: 748-754.
8. Gallagher EJ, LeRoith D,. 2011. Minireview: IGF, insulin, and cancer. Endocrinology 152: 2546-2551.
9. Ganat Y, Soni S, Chacon M, Schwartz ML, Vaccarino FM,. 2002. Chronic hypoxia up-regulates fibroblast growth factor ligands in the perinatal brain and induces fibroblast growth factor-responsive radial glial cells in the sub-ependymal zone. Neuroscience 112: 977-991.
10. Han YH, Kwon JH, Yu DY, Moon EY,. 2006. Inhibitory effect of peroxiredoxin II (Prx II) on Ras-ERK-NFkappaB pathway in mouse embryonic fibroblast (MEF) senescence. Free Radic Res 40: 1182-1189.
11. Hatada EN, Krappmann D, Scheidereit C,. 2000. NF-kappaB and the innate immune response. Curr Opin Immunol 12: 52-58.
12. Kang DW, Park MH, Lee YJ, Kim HS, Kwon TK, Park WS, Min do S,. 2008. Phorbol ester up-regulates phospholipase D1 but not phospholipase D2 expression through a PKC/Ras/ERK/NFkappaB-dependent pathway and enhances matrix metalloproteinase-9 secretion in colon cancer cells. J Biol Chem 283: 4094-4104.
13. Kawaguchi H, Oka H, Jingushi S, Izumi T, Fukunaga M, Sato K, Matsushita T, Nakamura K,. 2010. A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: A randomized, placebo-controlled trial. J Bone Miner Res 25: 2735-2743.
14. Khurana R, Simons M,. 2003. Insights from angiogenesis trials using fibroblast growth factor for advanced arteriosclerotic disease. Trends Cardiovasc Med 13: 116-122.
15. Khurana R, Zhuang Z, Bhardwaj S, Murakami M, De Muinck E, Yla-Herttuala S, Ferrara N, Martin JF, Zachary I, Simons M,. 2004. Angiogenesis-dependent and independent phases of intimal hyperplasia. Circulation 110: 2436-2443.
16. Korc M, Friesel RE,. 2009. The role of fibroblast growth factors in tumor growth. Curr Cancer Drug Targets 9: 639-651.
17. Kusuhara H, Itani Y, Isogai N, Tabata Y,. 2011. Randomized controlled trial of the application of topical β-FGF-impregnated gelatin microspheres to improve tissue survival in subzone II fingertip amputations. J Hand Surg Eur Vol 36: 455-460.
18. Liu S, Wu LC, Pang J, Santhanam R, Schwind S, Wu YZ, Hickey CJ, Yu J, Becker H, Maharry K, Radmacher MD, Li C, Whitman SP, Mishra A, Stauffer N, Eiring AM, Briesewitz R, Baiocchi RA, Chan KK, Paschka P, Caligiuri MA, Byrd JC, Croce CM, Bloomfield CD, Perrotti D, Garzon R, Marcucci G,. 2010. Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia. Cancer Cell 17: 333-347.
19. Maher P,. 1999. p38 mitogen-activated protein kinase activation is required for fibroblast growth factor-2-stimulated cell proliferation but not differentiation. J Biol Chem 274: 17491-17498.
20. Makino T, Jinnin M, Muchemwa FC, Fukushima S, Kogushi-Nishi H, Moriya C, Igata T, Fujisawa A, Johno T, Ihn H,. 2010. Basic fibroblast growth factor stimulates the proliferation of human dermal fibroblasts via the ERK1/2 and JNK pathways. Br J Dermatol 162: 717-723.
21. Nickel W, Rabouille C,. 2009. Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol 10: 148-155.
22. Prudovsky I, Tarantini F, Landriscina M, Neivandt D, Soldi R, Kirov A, Small D, Kathir KM, Rajalingam D, Kumar TK,. 2008. Secretion without Golgi. J Cell Biochem 103: 1327-1343.
23. Rajaiya J, Xiao J, Rajala RV, Chodosh J,. 2008. Human adenovirus type 19 infection of corneal cells induces p38 MAPK-dependent interleukin-8 expression. Virol J 5: 17.
24. Ribeiro DL, Pinto ME, Maeda SY, Taboga SR, Goes RM,. 2012. High-fat induced obesity associated with insulin-resistance increases FGF2 content and causes stromal hyperplasia in rat ventral prostate. Cell Tissue Res 349: 577-588.
25. Rossini M, Cheunsuchon B, Donnert E, Ma LJ, Thomas JW, Neilson EG, Fogo AB,. 2005. Immunolocalization of fibroblast growth factor-1 (FGF-1), its receptor (FGFR-1), and fibroblast-specific protein-1 (FSP-1) in inflammatory renal disease. Kidney Int 68: 2621-2628.
26. Rozenblatt-Rosen O, Mosonego-Ornan E, Sadot E, Madar-Shapiro L, Sheinin Y, Ginsberg D, Yayon A,. 2002. Induction of chondrocyte growth arrest by FGF: Transcriptional and cytoskeletal alterations. J Cell Sci 115: 553-562.
27. Villaudy J, Delbe J, Blat C, Desauty G, Golde A, Harel L,. 1991. An IGF binding protein is an inhibitor of FGF stimulation. J Cell Physiol 149: 492-496.
28. Xu RH, Peng Y, Fan J, Yan D, Yamagoe S, Princler G, Sredni D, Ozato K, Kung HF,. 2000. Histone acetylation is a checkpoint in FGF-stimulated mesoderm induction. Dev Dyn 218: 628-635.
29. Zelenin AV, Prudovsky IA,. 1989. Regulation of DNA synthesis investigated in heterokaryons of dividing and nondividing cells. Int Rev Cytol 117: 179-214.
30. Zhang G, Ichimura T, Maier JA, Maciag T, Stevens JL,. 1993. A role for fibroblast growth factor type-1 in nephrogenic repair. Autocrine expression in rat kidney proximal tubule epithelial cells in vitro and in the regenerating epithelium following nephrotoxic damage by S-(1,1,2,2-tetrafluoroethyl)- l -cysteine in vivo. J Biol Chem 268: 11542-11547.